203 related articles for article (PubMed ID: 32816122)
1. Genomic and epigenetic aberrations of chromosome 1p36.13 have prognostic implications in malignancies.
Naderi A
Chromosome Res; 2020 Dec; 28(3-4):307-330. PubMed ID: 32816122
[TBL] [Abstract][Full Text] [Related]
2. SRARP and HSPB7 are epigenetically regulated gene pairs that function as tumor suppressors and predict clinical outcome in malignancies.
Naderi A
Mol Oncol; 2018 May; 12(5):724-755. PubMed ID: 29577611
[TBL] [Abstract][Full Text] [Related]
3. Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies.
Naderi A
Cancer Rep (Hoboken); 2020 Oct; 3(5):e1267. PubMed ID: 32706923
[TBL] [Abstract][Full Text] [Related]
4. Integrated Genomics for Pinpointing Survival Loci within Arm-Level Somatic Copy Number Alterations.
Roy DM; Walsh LA; Desrichard A; Huse JT; Wu W; Gao J; Bose P; Lee W; Chan TA
Cancer Cell; 2016 May; 29(5):737-750. PubMed ID: 27165745
[TBL] [Abstract][Full Text] [Related]
5. Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors.
Glinsky GV
Cancer Lett; 2016 Oct; 381(1):176-93. PubMed ID: 27497790
[TBL] [Abstract][Full Text] [Related]
6. Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma.
Park AK; Kim P; Ballester LY; Esquenazi Y; Zhao Z
Neuro Oncol; 2019 Jan; 21(1):59-70. PubMed ID: 30053126
[TBL] [Abstract][Full Text] [Related]
7. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
8. Deconvolution of DNA methylation identifies differentially methylated gene regions on 1p36 across breast cancer subtypes.
Titus AJ; Way GP; Johnson KC; Christensen BC
Sci Rep; 2017 Sep; 7(1):11594. PubMed ID: 28912426
[TBL] [Abstract][Full Text] [Related]
9. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
[TBL] [Abstract][Full Text] [Related]
10. Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer.
Wrzeszczynski KO; Varadan V; Byrnes J; Lum E; Kamalakaran S; Levine DA; Dimitrova N; Zhang MQ; Lucito R
PLoS One; 2011; 6(12):e28503. PubMed ID: 22174824
[TBL] [Abstract][Full Text] [Related]
11. Detection of genetic alterations in gastric cancer patients from Saudi Arabia using comparative genomic hybridization (CGH).
Bibi F; Ali I; Naseer MI; Ali Mohamoud HS; Yasir M; Alvi SA; Jiman-Fatani AA; Sawan A; Azhar EI
PLoS One; 2018; 13(9):e0202576. PubMed ID: 30212456
[TBL] [Abstract][Full Text] [Related]
12. Glutamine Metabolism Regulators Associated with Cancer Development and the Tumor Microenvironment: A Pan-Cancer Multi-Omics Analysis.
Zou J; Du K; Li S; Lu L; Mei J; Lin W; Deng M; Wei W; Guo R
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573287
[TBL] [Abstract][Full Text] [Related]
13. 1p36 tumor suppression--a matter of dosage?
Henrich KO; Schwab M; Westermann F
Cancer Res; 2012 Dec; 72(23):6079-88. PubMed ID: 23172308
[TBL] [Abstract][Full Text] [Related]
14. Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis.
Cheung KJ; Johnson NA; Affleck JG; Severson T; Steidl C; Ben-Neriah S; Schein J; Morin RD; Moore R; Shah SP; Qian H; Paul JE; Telenius A; Relander T; Lam W; Savage K; Connors JM; Brown C; Marra MA; Gascoyne RD; Horsman DE
Cancer Res; 2010 Nov; 70(22):9166-74. PubMed ID: 20884631
[TBL] [Abstract][Full Text] [Related]
15. Expression of APITD1 is not related to copy number changes of chromosomal region 1p36 or the prognosis of uveal melanoma.
van Gils W; Mensink HW; Kilic E; Vaarwater J; Verbiest MM; Paridaens D; Luyten GP; de Klein A; Brüggenwirth HT
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4919-23. PubMed ID: 17962439
[TBL] [Abstract][Full Text] [Related]
16. Copy number rather than epigenetic alterations are the major dictator of imprinted methylation in tumors.
Martin-Trujillo A; Vidal E; Monteagudo-Sánchez A; Sanchez-Delgado M; Moran S; Hernandez Mora JR; Heyn H; Guitart M; Esteller M; Monk D
Nat Commun; 2017 Sep; 8(1):467. PubMed ID: 28883545
[TBL] [Abstract][Full Text] [Related]
17. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
[TBL] [Abstract][Full Text] [Related]
18. Genetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1, BAP1 and KDMC5, genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNA.
Kluzek K; Srebniak MI; Majer W; Ida A; Milecki T; Huminska K; van der Helm RM; Silesian A; Wrzesinski TM; Wojciechowicz J; Beverloo BH; Kwias Z; Bluyssen HAR; Wesoly J
Oncotarget; 2017 Apr; 8(17):28558-28574. PubMed ID: 28212566
[TBL] [Abstract][Full Text] [Related]
19. Chromosome X genomic and epigenomic aberrations and clinical implications in breast cancer by base resolution profiling.
Sun Z; Prodduturi N; Sun SY; Thompson EA; Kocher JP
Epigenomics; 2015 Oct; 7(7):1099-110. PubMed ID: 26039248
[TBL] [Abstract][Full Text] [Related]
20. Pan-cancer identification of clinically relevant genomic subtypes using outcome-weighted integrative clustering.
Arora A; Olshen AB; Seshan VE; Shen R
Genome Med; 2020 Dec; 12(1):110. PubMed ID: 33272320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
